Yi Li, a distinguished professor specializing in horticultural plant breeding and biotechnology at the University of Connecticut’s College of Agriculture, Health, and Natural Resources, has pioneered transformative techniques in genome editing. Li’s work tackles the profound challenge of reducing undesirable regulatory complications associated with traditional transgenic plants. His team’s breakthroughs promise to revolutionize how genome editing is applied, especially in economically vital crops.

Genome editing, exemplified by technologies such as CRISPR-Cas9, allows precise modifications to plants’ inherent genetic material. This technology circumvents the randomness of older breeding methods by targeting specific genes responsible for traits like drought resistance or heat tolerance. Despite this precision, the current standard methodology introduces foreign DNA sequences, including CRISPR components like Cas9, into plant cells. Consequently, edited plants often remain classified as GMOs, triggering strict regulatory measures worldwide.

The core challenge stems from the necessity to transiently integrate CRISPR-related genetic elements for editing while avoiding permanent insertion of foreign DNA. Conventional protocols produce transgenic plants that harbor stable foreign genes, complicating regulatory approval and public acceptance, and limiting rapid deployment at scale. In this context, Li’s research offers novel solutions that transcend existing bottlenecks by eliminating stable transgene integration.

In 2018, Li and colleagues introduced an innovative, transgene-free genome editing strategy employing Agrobacterium-mediated transient expression. This method harnesses Agrobacterium tumefaciens bacteria to transiently deliver CRISPR constructs into plant cells without permanently embedding foreign DNA into the plant genome. The transient CRISPR activity induces desired genetic edits before the bacterial DNA and associated transgenes are lost naturally through cell division, producing non-GMO edited plants.

This transient editing technique is exceptionally relevant for perennial crops or plants reproduced vegetatively, where traditional breeding cycles are prolonged. By bypassing stable transgene incorporation, the method significantly hastens the generation of edited plants, aligning with industry needs for rapid crop improvement while circumventing GMO classification constraints in many jurisdictions.

Despite promising prospects, initial iterations of transient editing faced efficiency limitations, particularly regarding the selection of successfully edited cells. Li and his collaborators have now driven substantial advances in this area. Their latest work, recently published in the high-impact journal Horticulture Research, demonstrates a marked enhancement in editing efficiency using citrus plants as an experimental model.

The research addresses a longstanding technical obstacle — differentiating plants transiently expressing CRISPR genes from uninfected cells during the editing window. By introducing kanamycin, an antibiotic, for a brief three-to-four-day selection period during Agrobacterium infection, they leveraged linked CRISPR gene expression to confer temporary antibiotic resistance. This approach effectively suppresses non-infected cells, enriching the population of edited cells without permanently introducing antibiotic resistance genes.

Remarkably, this chemical selection scheme elevated the genome editing efficiency by a factor of seventeen compared to Li’s prior 2018 protocol. This leap in editing performance not only reduces time and resource expenditure but also expands the method’s applicability across diverse crop species beyond citrus, heralding new opportunities for agriculture innovation.

Citrus crops, critically threatened by Huanglongbing disease (also known as citrus greening), epitomize urgent agricultural challenges. This devastating bacterial disease has decimated nearly 70% of Florida’s citrus trees, severely impacting U.S. citrus production. Developing genome-edited citrus variants with innate resistance offers a potential lifeline, and Li’s enhanced transgene-free editing platform could accelerate these vital breeding programs.

Beyond citrus, the implications of this technology span a broad spectrum of agricultural commodities. The capability to generate non-GMO genome-edited plants rapidly addresses regulatory bottlenecks and public concerns, facilitating commercialization and adoption. The method’s simplicity and scalability make it an attractive alternative to more complex or time-intensive transgene-free editing methods currently available.

Furthermore, Li’s refined approach exemplifies how biochemical tools and molecular biology intersect to innovate practical plant breeding solutions. The strategic use of transient antibiotic selection during bacterial-mediated transformation is a clever adaptation that elegantly balances editing efficacy, speed, and regulatory compliance.

As genome editing continues to reshape the future of agriculture, innovations like those from Li’s lab will be critical to delivering resilient, sustainable crops tailored for global food security. By circumventing the pitfalls of stable foreign DNA integration while maximizing editing precision, these advances empower breeders and farmers alike to meet tomorrow’s challenges.

In sum, this state-of-the-art Agrobacterium-mediated transient editing enhanced with short-term chemical selection stands to democratize access to gene-edited crops ideally positioned beyond existing GMO regulatory frameworks. It charts a compelling path forward for plant biotechnology with profound implications for food systems worldwide.

Subject of Research: Not applicable

Article Title: Substantial enhancement of Agrobacterium-mediated transgene-free genome editing via short-term chemical selection using citrus as a model plant

News Publication Date: 19-Sep-2025

Web References: 10.1093/hr/uhaf153

References: Li et al. (2025) Horticulture Research

Image Credits: Jason Sheldon/UConn Photo

Keywords: Crop science, Genetically modified foods

Inspired by nature’s own evolutionary arms race between bacteria and their viral foes, an international team of researchers has pioneered a novel genome editing technique that introduces a fundamentally different approach to modifying DNA. The collaborative effort, spearheaded by scientists at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Germany in concert with partners at North Carolina State University and ETH Zurich, culminated in the development of “append editing.” This technique exploits a sophisticated biochemical pathway originally evolved in bacteria as a defense system against bacteriophages—viruses that infect bacterial cells. Unlike existing methods that cleave or replace DNA nucleotides, append editing subtly modifies the DNA by attaching small chemical groups, thereby adding a new layer of control over genome manipulation.

At the heart of this innovation lies the interplay between two bacterial enzymes, DarT2 and DarG, which work in concert to protect bacteria from viral invasion. When a bacteriophage injects its genetic material, DarT2 acts by covalently attaching a chemical marker known as ADP-ribose to specific sites on the viral DNA, effectively freezing replication and halting the virus’s ability to proliferate. This antiviral modification acts as a molecular “sticky note,” marking the viral genome and signaling cellular machinery to disrupt its copying. In contrast, DarG serves as a safeguard mechanism that erases these modifications when no viral threat is present, thus preventing unintended interference with the host’s own DNA processes. This dynamic system—finely balanced between defense and self-preservation—provided the blueprint for the append editing method that converts a defensive reaction into a targeted genome editing tool.

Append editing diverges sharply from classical genome editing methods by introducing chemical attachments directly onto DNA bases without cutting the helix. This modality draws an analogy to appending a sticky note onto a page in a notebook, rather than erasing or rewriting the text itself. The chemical groups added—ADP-ribose molecules—serve as signals that prompt the cell’s inherent repair systems to execute precise genetic changes. Remarkably, the nature of these changes differs substantially depending on the organism involved. In bacteria, the appended ADP-ribose tags stimulate an elaborate templated repair process, guiding the incorporation of large, pre-designed sequences into the genome with high fidelity. Conversely, in eukaryotic cells, which include fungi, plants, and human cells, the modification prompts a distinct response whereby the edited DNA bases undergo identity changes, effectively converting one base into another and causing targeted base mutagenesis.

This organism-specific variance in DNA repair outcomes was unexpected and highlights the complexity of cellular responses to chemical DNA modifications. Traditional editing tools generally yield similar types of genetic alterations across different species, but append editing reveals that the biochemical context of the host cell profoundly influences the editing trajectory. According to Chase Beisel, leading the affiliated department at HIRI, this discovery underscores an intrinsic flexibility within the DNA repair landscape, which can be harnessed to tailor genome editing strategies uniquely suited to each biological context. Constantinos Patinios, a former postdoctoral researcher involved in the study, emphasizes that this mechanistic insight opens unexplored avenues for refining genetic manipulation techniques.

The potential applications of append editing span a broad spectrum of biological research and biotechnology. In microbiology, this tool offers an unprecedented capacity to introduce large, complex genetic modifications into bacterial genomes with surgical precision. Such capability could be harnessed to engineer beneficial microbes that reside in the human body, enhancing their functional attributes to support health. Furthermore, pathogens can be systematically dissected and modified to elucidate mechanisms of infectivity and antimicrobial resistance. Within the realm of eukaryotic cells, including human tissue, base mutagenesis induced by append editing offers a gentler alternative to conventional editing practices. This could be transformational for therapeutic interventions aimed at rectifying inherited genetic disorders, minimizing unintended DNA damage and immune responses.

While the promise of append editing is clear, translating this novel technology into clinical and agricultural practice requires further rigorous research and development. Key challenges remain in optimizing delivery systems, ensuring specificity, and fully characterizing the long-term consequences of ADP-ribose modifications within diverse cell types. Nonetheless, the researchers express strong optimism about the translational potential of DarT2-based editing, symbolizing a new chapter in the utilization of natural bacterial defense mechanisms for precision genome engineering. This advance exemplifies the innovative spirit that emerges when scientists look to nature’s own molecular inventions for inspiration.

The study detailing this breakthrough was recently published online ahead of print in Nature Biotechnology, highlighting the collaborative synergy between institutions spanning three countries. The research was generously funded by a constellation of esteemed organizations, including the U.S. National Institutes of Health, the European Research Council via an ERC Consolidator Grant, the Horizon 2020 program, and the North Carolina Biotechnology Center, among others. Syngenta’s involvement reflects industrial interest in harnessing these advances for agricultural biotechnology. Additional support provided by international fellowships and foundations underscores the global recognition of this promising technology.

Fundamental to the progress achieved at the Helmholtz Institute for RNA-based Infection Research (HIRI) is the institute’s unique focus on RNA biology intersecting with infection research. HIRI’s strategic vision aims to leverage emerging molecular insights to devise innovative therapies for combating infectious diseases. As a pivotal site within the Braunschweig Helmholtz Centre for Infection Research, operated in partnership with the Julius-Maximilians-Universität Würzburg, HIRI’s multidisciplinary approach combines expertise in molecular biology, microbiology, and biomedical engineering. Their collective efforts illustrate how basic scientific discovery continues to fuel groundbreaking technological innovation.

Equally notable is the Helmholtz Centre for Infection Research’s (HZI) broader mission to illuminate the complexities of bacterial and viral infections, as well as the host immune system’s dynamic responses. By harnessing natural compounds and biotechnological methods, HZI researchers aim to translate foundational knowledge into novel anti-infective therapies and vaccines. The development of append editing, springing from bacterial defense mechanisms, perfectly aligns with this mission and confirms the potential for infectious disease research to catalyze advances far beyond its immediate field.

In summary, append editing heralds a significant expansion of the genome editing toolbox, introducing a novel biochemical mechanism that enhances precision and versatility. Drawing from nature’s evolutionary battlefronts between microbes and viruses, this technology enables modifications previously unattainable by standard gene-editing approaches. Its distinctive ability to induce different types of genetic changes depending on the targeted organism offers unprecedented control and flexibility, setting the stage for transformative applications in biotechnology, medical therapy, and fundamental research. This breakthrough underscores the boundless potential when technology meets biological insight, promising to reshape the future landscape of genetic engineering.

Subject of Research: Cells

Article Title: Targeted DNA ADP-ribosylation triggers templated repair in bacteria and base mutagenesis in eukaryotes

Web References:

• https://www.helmholtz-hiri.de
• https://www.helmholtz-hzi.de/en
• DOI: http://dx.doi.org/10.1038/s41587-025-02802-w

Keywords: Targeted genome editing, Genetic engineering